Historical salary details - Dr. Helen I. Torley, M.R.C.P.,MB.Ch.B., Director, President and Chief Executive Officer, Halozyme Therapeutics Inc.
Dr. Helen I. Torley, M.R.C.P.,MB.Ch.B. has been the Director, President and Chief Executive Officer of Halozyme Therapeutics Inc. since 20 Mar 2014 and his latest salary was 12.7 M. View his historical salary.
Dr. Helen I. Torley, M.R.C.P.,Mb.Ch.B.
Director, President and Chief Executive Officer
$ 12.7 M
Gross Remuneration
-
Current Company
Halozyme Therapeutics Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 12.7 M | - |
| 2023 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | - | - |
| 2022 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 9.7 M | 30.1 % |
| 2021 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 7.5 M | 14.3 % |
| 2021 | Halozyme Therapeutics Inc. | - | 7.5 M | 14.3 % |
| 2020 | Halozyme Therapeutics Inc. | - | 6.5 M | 11.3 % |
| 2020 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 6.5 M | 11.3 % |
| 2020 | Halozyme Therapeutics Inc. | - | 6.5 M | 11.3 % |
| 2019 | Halozyme Therapeutics Inc. | - | 5.9 M | 1.0 % |
| 2019 | Halozyme Therapeutics Inc. | - | 5.9 M | 1.0 % |
| 2019 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 5.9 M | 1.0 % |
| 2018 | Halozyme Therapeutics Inc. | - | 5.8 M | 12.0 % |
| 2018 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 5.8 M | 12.0 % |
| 2018 | Halozyme Therapeutics Inc. | - | 5.8 M | 12.0 % |
| 2017 | Halozyme Therapeutics Inc. | - | 5.2 M | 6.8 % |
| 2017 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 5.2 M | 6.8 % |
| 2017 | Halozyme Therapeutics Inc. | - | 5.2 M | 6.8 % |
| 2016 | Halozyme Therapeutics Inc. | - | 4.9 M | 5.1 % |
| 2016 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 4.9 M | 5.1 % |
| 2016 | Halozyme Therapeutics Inc. | - | 4.9 M | 5.1 % |
| 2015 | Halozyme Therapeutics Inc. | - | 4.6 M | -55.6 % |
| 2015 | Halozyme Therapeutics Inc. | - | 4.6 M | -55.6 % |
| 2015 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 4.6 M | -55.6 % |
| 2014 | Halozyme Therapeutics Inc. | - | 10.4 M | - |
| 2014 | Halozyme Therapeutics Inc. | - | 10.4 M | - |
| 2014 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | 10.4 M | - |
| 2013 | Halozyme Therapeutics Inc. | Director, President and Chief Executive Officer | - | - |